HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

Histone deacetylases (HDACs) compact chromatin structure and repress gene transcription. In schizophrenia, clinical studies demonstrate that HDAC inhibitors are efficacious when given in combination with atypical antipsychotics. However, the molecular mechanism that integrates a better response to a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kurita, Mitsumasa, Holloway, Terrell, García-Bea, Aintzane, Kozlenkov, Alexey, Friedman, Allyson K., Moreno, José L., Heshmati, Mitra, Golden, Sam A., Kennedy, Pamela J., Takahashi, Nagahide, Dietz, David M., Mocci, Giuseppe, Gabilondo, Ane M., Hanks, James, Umali, Adrienne, Callado, Luis F., Gallitano, Amelia L., Neve, Rachael L., Shen, Li, Buxbaum, Joseph D., Han, Ming-Hu, Nestler, Eric J., Meana, J. Javier, Russo, Scott J., González-Maeso, Javier
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3431440/
https://ncbi.nlm.nih.gov/pubmed/22864611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3181
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים